Fitzgerald Rebecca

Rebecca Fitzgerald is a Professor of Cancer Prevention at the University of Cambridge and Interim Director of the MRC Cancer Unit. Her research focuses on the early detection of oesophageal and gastric cancers, particularly through molecular phenotyping, genomics, and non-endoscopic diagnostic tools like the Cytosponge. She has held leadership roles including Director of the Early Cancer Institute (2022) and leads the CRUK International Alliance Cancer Early Detection program in Cambridge.

• Barrett's oesophagus
• Oesophageal adenocarcinoma
• Genomic biomarkers
• Non-endoscopic diagnostics
• Cancer prevention

Her publications highlight advancements in mutational signatures, deep learning applications for triage-driven diagnosis, and genomic prediction of cancer years before transformation. These works align with her broader goals of improving clinical early detection strategies.

• Fellow of the Royal Society (2024)
• Don Listwin Early Detection Award (2022)
• Elected EMBO Member (2021)
• Lister Institute Research Prize (2008)
• Westminster Medal (2004)

Fitzgerald has trained over 30 PhD students, served on editorial boards, and contributed to national and international cancer screening policy. She actively engages in patient and public involvement through initiatives like Heartburn Cancer UK.